Gene Expression Analysis in Polycystic Ovary Syndrome (PCOS) Treated with <i>Tinospora cordifolia</i>: Insights into Therapeutic Mechanisms
Background: Polycystic Ovary Syndrome (PCOS) is an ailment with ovarian dysfunction accompanying cardinal features of hyperinsulinemia and hyperandrogenism. Ayurvedic and traditional medical practises frequently use the plant Tinospora cordifolia due to its numerous therapeutic benefits, as it contains alkaloids, terpenoids, flavonoids, phenolic chemicals, tannins, and steroids. Niosomes have recently attracted increased interest as a new drug delivery mechanism because of their biodegradability, decreased toxicity, enhanced therapeutic effectiveness, and augmentation of absorption. Aim: In this study, an effort has been made to determine the effects of giving mifepristone-induced PCOS rats an Ethanolic Leaf Extract of T. cordifolia (ELETC) and T. cordifolia loaded phytoniosomes (nELETC) on the downregulation of geneson the genes, such as Insulin-like Growth Factor-1 (IGF-1), IGF-2 and Phosphatase and Tensin (PTEN) involved in the insulin signalling pathway. Methods: PCOS was induced by administering mifepristone (4mg/kg b.w.) daily for a period of 8 days to the female rats and confirmed by a persistent oestrous cycle. The rats that developed PCOS were treated with 200mg /kg b. w. each ELETC and nELETC per oral for 28 days. The ovaries were collected for gene expression study using semi-quantitative real-time Polymerase Chain Reaction (PCR) analysis. Result: ELETC and nELETC extract treatment on the IGF-1, IGF-2 and PTEN gene showed a good impact on the expression patterns. In PCOS-induced group 2 rats, there was a 1.72-fold change in the mRNA expression of the IGF-1 gene, a 0.6-fold increase in the IGF-2 gene and a 0.64-fold increase in the PTEN gene. The expression of group 3 and group 4 rats when treated with ELETC and nELETC was reduced to 0.72 fold and 0.42 fold, respectively, for the IGF-1 gene, 0.38 and 0.36 fold, respectively, for the IGF-2 gene and 0.45 and 0.31 fold, respectively, for the PTEN gene. The reduction in the expression pattern